ALLR - CIK 0001860657
The table below shows Allarity Therapeutics, Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $14.69M | $19.53M | $166.00K | - | - |
| Short-term investments | - | - | - | - | - |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Total current assets | $17.93M | $22.34M | $1.97M | $4.97M | $21.05M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment |
| $330.00K |
| $309.00K |
| $20.00K |
| $21.00K |
| $8.00K |
| Goodwill | - | - | - | - | - |
| Total assets | $18.26M | $22.65M | $11.86M | $14.54M | $49.63M |
| Accounts payable | $4.28M | $4.18M | $8.42M | $6.25M | $698.00K |
| Total current liabilities | $8.43M | $10.84M | $14.17M | $11.22M | $20.72M |
| Long-term debt | - | $2.69M | - | $2.64M | - |
| Total liabilities | $8.43M | $10.84M | $14.61M | $12.65M | $30.85M |
| Retained earnings | -$130.20M | -$118.97M | -$94.45M | -$82.55M | -$66.49M |
| Total equity | $9.83M | $11.81M | -$2.75M | -$113.00K | $18.15M |